Curcumin blunts epithelial-mesenchymal transition to alleviate invasion and metastasis of prostate cancer through the JARID1D demethylation
Authors:
Open Access
- 1 September 2024
- journal article
- research article
- Published by Springer Nature in Cancer Cell International
- Vol. 24 (1) , 1-14
Abstract
Prostate cancer (PCa) is one of the most common and prevalent cancers in men worldwide. The majority of PCa-related deaths result from metastasis rather than primary tumors. Several studies have focused on the relationship between male-specific genes encoded on the Y chromosome and PCa metastasis; however, the relationship between the male specific protein encoded on the Y chromosome and tumor suppression has not been fully clarified. Here, we report a male specific protein of this type, the histone H3 lysine 4 (H3K4) demethylase JARID1D, which has the ability to inhibit the gene expression program related to cell invasion, and can thus form a phenotype that inhibits the invasion of PCa cells. However, JARID1D exhibits low expression level in advanced PCa, and which is related to rapid invasion and metastasis in patients with PCa. Curcumin, as a multi-target drug, can enhance the expression and demethylation activity of JARID1D, affect the androgen receptor (AR) and epithelial-mesenchymal transition (EMT) signaling cascade, and inhibit the metastatic potential of castration resistant cancer (CRPC). These findings suggest that using curcumin to increase the expression and demethylation activity of JARID1D may be a feasible strategy to inhibit PCa metastasis by regulating EMT and AR. Knockdown of JARID1D can enhance the invasion and metastasis ability of prostate cancer cells. Curcumin improves the expression and demethylation activity of JARID1D. Curcumin can stimulate the JARID1D/AR/EMT signaling cascade through demethylation to inhibit the metastatic potential of castration-resistant prostate cancer.Keywords
Funding Information
- The National Natural Science Foundation of China (32070532)
- Shanxi Province Innovation Capability Support Plan (2022PT-38)
This publication has 36 references indexed in Scilit:
- Curcumin: An epigenetic regulator and its application in cancerBiomedicine & Pharmacotherapy, 2022
- FcγRIIIa receptor interacts with androgen receptor and PIP5K1α to promote growth and metastasis of prostate cancerMolecular Oncology, 2022
- Curcumin, the active substance of turmeric: its effects on health and ways to improve its bioavailabilityJournal of the Science of Food and Agriculture, 2021
- Inhibition of noncanonical Wnt pathway overcomes enzalutamide resistance in castration‐resistant prostate cancerThe Prostate, 2019
- Castration-resistant prostate cancer patients who had poor response on first androgen deprivation therapy would obtain certain clinical benefit from early docetaxel administrationInternational Journal of Clinical Oncology, 2019
- Histone Demethylase RBP2 Is Critical for Breast Cancer Progression and MetastasisCell Reports, 2014
- Selection of Bone Metastasis Seeds by Mesenchymal Signals in the Primary Tumor StromaCell, 2013
- The Androgen Receptor Induces a Distinct Transcriptional Program in Castration-Resistant Prostate Cancer in ManCancer Cell, 2013
- Androgen Receptor Regulates a Distinct Transcription Program in Androgen-Independent Prostate CancerCell, 2009
- Sexually dimorphic gene expression in the heart of mice and menJournal of Molecular Medicine, 2007